Beromun (tasonermin) is a protein pharmaceutical. Tasonermin was first approved as Beromun on 1999-04-12. It has been approved in Europe to treat sarcoma.
Trade Name |
Beromun |
Common Name |
Tasonermin |
Indication |
sarcoma |
Drug Class |
Growth factors: tumor necrosis factors |